Roivant Sciences revenue and financials
$35.53Change from previous close: −0.70%Absolute change: −$0.25
In the fiscal year ended March 2026, Roivant Sciences reported revenue of $8.26M (−71.57% year over year). The net loss was $299.77M.
Fiscal year ending in March. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- −71.57%
- FY to Mar 2026 vs FY to Mar 2025
- Net margin
- -3,629.2%
- FY to Mar 2025: -592.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 5,306 | 5,709 | 5,225 | 5,063 | 5,033 | 5,437 | 5,792 | 6,206 | 6,496 | 7,222 | 7,313 | 2,066 |
| Current assets | 4,742 | 5,167 | 4,660 | 4,512 | 4,616 | 5,000 | 5,364 | 5,801 | 6,001 | 6,732 | 6,807 | 1,552 |
| Cash and equivalents | 1,248 | 1,419 | 1,478 | 1,237 | 1,238 | 2,715 | 1,991 | 1,959 | 5,679 | 6,495 | 6,671 | 1,408 |
| Short-term investments | 2,594 | 2,873 | 3,052 | 3,149 | 3,265 | 2,171 | 3,156 | 3,428 | — | — | — | — |
| Receivables | 21.6 | 770 | — | — | — | 0.0 | 144 | 22.7 | 215 | — | 63.2 | 54.6 |
| Inventory | — | — | — | — | — | — | — | — | 34.0 | — | 5.2 | 4.9 |
| Net property, plant and equipment | 90.2 | 92.4 | 97.0 | 111 | 102 | 101 | 104 | 56.7 | 63.2 | 59.3 | 68.8 | 73.1 |
| Other intangible assets | — | — | — | — | — | — | — | — | 136 | — | 150 | 141 |
| Long-term investments | 445 | 408 | 434 | 412 | 284 | 303 | 290 | 311 | 263 | 248 | 240 | 250 |
| Current liabilities | 284 | 281 | 152 | 134 | 114 | 149 | 141 | 556 | 215 | 267 | 245 | 266 |
| Accounts payable | 25.1 | 18.0 | 13.3 | 15.1 | 11.6 | 23.7 | 23.7 | 25.1 | 27.7 | 14.0 | 35.2 | 44.1 |
| Long-term debt | — | — | — | — | — | — | — | — | 312 | — | 403 | 389 |
| Total debt | 107 | 107 | 109 | 98.8 | 99.7 | — | — | — | — | — | — | — |
| Total liabilities | 385 | 416 | 251 | 257 | 217 | 250 | 256 | 626 | 601 | 774 | 728 | 740 |
| Total equity (incl. minority) | 4,922 | 5,292 | 4,974 | 4,805 | 4,816 | 5,187 | 5,536 | 5,580 | 5,895 | 6,449 | 6,585 | 1,326 |
| Retained earnings | -900 | -502 | -695 | -429 | -316 | 116 | 460 | 396 | 671 | 576 | 727 | -4,369 |
| Minority interest | 691 | 765 | 705 | 443 | 470 | 500 | 346 | 427 | 460 | 480 | 495 | 377 |